Literature DB >> 23313026

Incidence and risk factors for hospital-acquired Clostridium difficile infection among inpatients in an orthopaedic tertiary care hospital.

K A Campbell1, M S Phillips, A Stachel, J A Bosco, S A Mehta.   

Abstract

The aim of this retrospective study was to identify risk factors for hospital-acquired Clostridium difficile infection (HA-CDI) in orthopaedic patients. Thirty-two HA-CDI cases were each matched with two controls. Incidence rate was 0.33 cases per 1000 patient-days. Univariate analyses showed that surgery >24 h after admission, antibiotics for treatment, and proton pump inhibitors were associated with HA-CDI. Multivariate analyses revealed that surgery >24 h after admission was associated with HA-CDI. Patients hospitalized before surgery had a greater risk of HA-CDI, suggesting opportunities to reduce environmental exposure to C. difficile by timelier preoperative medical optimization in the outpatient setting.
Copyright © 2012 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23313026     DOI: 10.1016/j.jhin.2012.11.009

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  10 in total

1.  Implementing an intensified antibiotic stewardship programme targeting daptomycin use in orthopaedic surgery: a cost-benefit analysis from the hospital perspective.

Authors:  Johannes P Borde; Sarah Nussbaum; Stefanie Hauser; Philip Hehn; Johannes Hübner; Gabriela Sitaru; Sebastian Köller; Bruno Schweigert; Katja deWith; Winfried V Kern; Klaus Kaier
Journal:  Infection       Date:  2015-10-16       Impact factor: 3.553

2.  Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.

Authors:  Tadayuki Oshima; Liping Wu; Min Li; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2017-07-25       Impact factor: 7.527

3.  Clinical Determinants Predicting Clostridioides difficile Infection among Patients with Chronic Kidney Disease.

Authors:  Łukasz Lis; Andrzej Konieczny; Michał Sroka; Anna Ciszewska; Kornelia Krakowska; Tomasz Gołębiowski; Zbigniew Hruby
Journal:  Antibiotics (Basel)       Date:  2022-06-08

4.  Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.

Authors:  David M Faleck; Hojjat Salmasian; E Yoko Furuya; Elaine L Larson; Julian A Abrams; Daniel E Freedberg
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

5.  Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients.

Authors:  Klaus Nissle; Daniel Kopf; Alexander Rösler
Journal:  BMC Geriatr       Date:  2016-11-15       Impact factor: 3.921

Review 6.  Risk factors for Clostridium difficile infections - an overview of the evidence base and challenges in data synthesis.

Authors:  Paul Eze; Evelyn Balsells; Moe H Kyaw; Harish Nair
Journal:  J Glob Health       Date:  2017-06       Impact factor: 4.413

Review 7.  Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.

Authors:  Anca Trifan; Carol Stanciu; Irina Girleanu; Oana Cristina Stoica; Ana Maria Singeap; Roxana Maxim; Stefan Andrei Chiriac; Alin Ciobica; Lucian Boiculese
Journal:  World J Gastroenterol       Date:  2017-09-21       Impact factor: 5.742

8.  Bacterial uropathogens and susceptibility testing among patients diagnosed with urinary tract infections at Hiwot Fana Specialized University Hospital, Eastern Ethiopia.

Authors:  Tewodros Tesfa; Yohannes Baye; Mekonnen Sisay; Firehiwot Amare; Tigist Gashaw
Journal:  SAGE Open Med       Date:  2021-03-16

9.  The Burden of Clostridium difficile after Cervical Spine Surgery.

Authors:  Javier Z Guzman; Branko Skovrlj; Edward S Rothenberg; Young Lu; Steven McAnany; Samuel K Cho; Andrew C Hecht; Sheeraz A Qureshi
Journal:  Global Spine J       Date:  2015-08-10

10.  Analysis of risk factors and clinical manifestations associated with Clostridium difficile disease in Serbian hospitalized patients.

Authors:  Stojanović Predrag
Journal:  Braz J Microbiol       Date:  2016-07-25       Impact factor: 2.476

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.